|
|
3SBio (SSRX) Shares Downgraded to Hold by Auriga Analysts - LocalizedUSA |
LocalizedUSA
The Company's recombinant, or genetically engineered, protein-based products and product candidates are designed to address large markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.
|
|
|
New surgical procedure lowers blood pressure - Zee News |
Zee News
Toronto: A minimally invasive surgical procedure called renal denervation can significantly lower blood pressure (BP) in patients who are unable to control it with drugs. The nearly painless procedure has been tried out for the first time by doctors at ...
Canada's first renal denervation procedure to reduce high blood pressure
|
|
Progress made on dialysis center - Franklin Press |
Franklin Press
By Colin McCandless Macon County has met the state's need determination for a dialysis center and has the green light to move toward establishing a kidney dialysis facility. Gov. Beverly Perdue has signed off on State Health Coordinating Council (SHCC)
|
|
JACC: Baseline anemia doesn't predict death in HF, renal dysfunction outpatients - Cardiovascular Business |
Cardiovascular Business
Baseline anemia was not an independent predictor of all-cause mortality in outpatients with heart failure (HF) and severe renal dysfunction or advanced heart disease in a study published Jan. 24 in the Journal of the American College of Cardiology.
|
|
Rituximab Ineffective as Lupus Nephritis Add-On Therapy - Renal and Urology News |
Renal and Urology News
As part of the Lupus Nephritis Assessment with Rituximab (LUNAR) trial, American and Mexican investigators led by Brad H. Rovin, MD, Director of Nephrology at the Ohio State College of Medicine in Columbus, Ohio, studied 144 patients (aged 16-75 years)
|
|
|
|
|
<< Start < Prev 531 532 533 534 535 536 537 538 539 540 Next > End >>
|
|
Page 539 of 2630 |